Antibody-mediated modulation of Cryptococcus neoformans infection is dependent on distinct Fc receptor functions and IgC subclasses

Journal of Experimental Medicine

Volumn 187, Issue 4, 1998, Pages 641-648

  Yuan, RuiRong ^a   Clynes, Raphael ^b   Oh, Jin ^a   Ravetch, Jeffrey V ^b   Scharff, Matthew D ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN G3; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; FUNGUS GROWTH; GENE DELETION; INTERNALIZATION; MACROPHAGE; MOUSE; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; ROSETTE FORMATION; SHEEP ERYTHROCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY REACTIONS; CELLS, CULTURED; COCULTURE TECHNIQUES; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; IMMUNOGLOBULIN G; MACROPHAGES; MICE; MICE, INBRED C57BL; PHAGOCYTOSIS; RECEPTORS, FC; ROSETTE FORMATION;

EID: 0032536375     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.187.4.641     Document Type: Article

References (33)

1. Zuger, A., E. Louie, R.S. Holzman, M.S. Simberkoff, and J.J. Rahal. 1986. Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment. Ann. Intern. Med. 104:234-240.
2. Mukherjee, J., M.D. Scharff, and A. Casadevall. 1992. Protective murine monoclonal antibodies to Cryptococcus neoformans. Infect. Immun. 60:4534-4541.
3. Mukherjee, J., M.D. Scharff, and A. Casadevall. 1994. Cryptococcus neoformans infection can elicit protective antibodies in mice. Can. J. Microbiol. 40:888-892.
4. Nussbaum, G., R. Yuan, A. Casadevall, and M.D. Scharff. 1996. Immunoglobulin G3 blocking antibodies to the fungal pathogen Cryptococcus neoformans. J. Exp. Med. 183:1905-1909.
5. Yuan, R., A. Casadevall, G. Spira, and M.D. Scharff. 1995. Isotype switching from IgG3 to IgG1 converts a nonprotective murine antibody to Cryptococcus neoformans into a protective antibody. J. Immunol. 154:1810-1816.
6. Tomlinson, S. 1993. Complement defense mechanisms. Curr. Opin. Immunol. 5:83-89.
7. Lipscomb, M.F., T. Alvarellos, G.B. Toews, R. Tompkins, Z. Evans, G. Koo, and V. Kumar. 1987. Role of natural killer cells in resistance to Cryptococcus neoformans infections in mice. Am. J. Pathol. 128:354-361.
8. Levitz, S.M. 1992. Overview of host defenses in fungal infections. Clin. Infect. Dis. 14(Suppl.):S37-42.
9. Junghans, R.P. 1997. Finally: the Brambell receptor (FcRB). Mediator of transmission of immunity and protection from catabolism for IgG. Immunol. Res. 16:29-57.
10. Ravetch, J.V., and J.P. Kinet. 1991. Fc receptors. Annu. Rev. Immunol. 9:457-492.
11. Hulett, M.D., and P.M. Hogarth. 1994. Molecular basis of Fc receptor function. Adv. Immunol. 57:1-127.
12. Daeron, M. 1997. Fc receptor biology. Annu. Rev. Immunol. 15:203-234.
13. Ravetch, J.V. 1994. Fc receptors: rubor redux. Cell. 78: 553-560.
14. Beaven, M.A., and H. Metzger. 1993. Signal transduction by Fc receptors: the Fc epsilon RI case. Immunol. Today. 14: 222-226.
15. Ra, C., M.H. Jouvin, U. Blank, and J.P. Kinet. 1989. A macrophage Fc gamma receptor and the mast cell receptor for IgE share an identical subunit. Nature. 341:752-754.
16. Kurosaki, T., I. Gander, and J.V. Ravetch. 1991. A subunit common to an IgG Fc receptor and the T-cell receptor mediates assembly through different interactions. Proc. Natl. Acad. Sci. USA. 88:3837-3841.
17. Takai, T., M. Li, D. Sylvestre, R. Clynes, and J.V. Ravetch. 1994. FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell. 76:519-529.
18. Ono, M., S. Bolland, P. Tempst, and J.V. Ravetch. 1996. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc(gamma)RIIB. Nature. 383:263-266.
19. Ono, M., H. Okada, S. Bolland, S. Yanagi, T. Kurosaki, and J.V. Ravetch. 1997. Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling. Cell. 90:293-301.
20. Takai, T., M. Ono, M. Hikida, H. Ohmori, and J.V. Ravetch. 1996. Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice. Nature. 379:346-349.
21. Casadevall, A., J. Mukherjee, S.J. Devi, R. Schneerson, J.B. Robbins, and M.D. Scharff. 1992. Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection. J. Infect. Dis. 165:1086-1093.
22. Diamond, B., and M.D. Scharff. 1980. IgG1 and IgG2b share the Fc receptor on mouse macrophages. J. Immunol. 125: 631-633.
23. Mukherjee, S., S.C. Lee, and A. Casadevall. 1995. Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophages. Infect. Immun. 63: 573-579.
24. Mukherjee, J., L.S. Zuckier, M.D. Scharff, and A. Casadevall. 1994. Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B. Antimicrob. Agents Chemother. 38:580-587.
25. Diamond, B., B.R. Bloom, and M.D. Scharff. 1978. The Fc receptors of primary and cultured phagocytic cells studied with homogeneous antibodies. J. Immunol. 121:1329-1333.
26. Diamond, B., and D.E. Yelton. 1981. A new Fc receptor on mouse macrophages binding IgG3. J. Exp. Med. 153:514-519.
27. Yuan, R.R., A. Casadevall, J. Oh, and M.D. Scharff. 1997. T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice. Proc. Natl. Acad. Sci. USA. 94: 2483-2488.
28. Wirthmueller, U., T. Kurosaki, M.S. Murakami, and J.V. Ravetch. 1992. Signal transduction by FcγRIII (CD16) is mediated through the γ chain. J. Exp. Med. 175:1381-1390.
29. Ravetch, J.V. 1997. Fc receptors. Curr. Opin. Immunol. 9: 121-125.
30. Casadevall, A., and M.D. Scharff. 1991. The mouse antibody response to infection with Cryptococcus neoformans: VH and VL usage in polysaccharide binding antibodies. J. Exp. Med. 174:151-160.
31. 30a. Takechi, Y., Y. Moroi, A. Houghton, and J.V. Ravetch. 1998. Fc receptors are required in passive and active immunity to melanoma. Proc. Natl. Acad. Sci. USA. 95:652-656.
32. Sylvestre, D.L., and J. Ravetch. 1994. Fc receptors initiate the Arthus reaction: redefining the inflammatory cascade. Science. 265:1095-1098.
33. Weinshank, R.L., A.D. Luster, and J.V. Ravetch. 1998. Function and regulation of murine macrophage-specific IgG Fc receptor, FcγR-α J. Exp. Med. 167:1909-1925.